AKT1 and non-small cell lung carcinoma: ROR1 silencing in non-small cell lung cancer (NSCLC) cell lines led to decreased activity of the PI3K/AKT/mTOR signaling pathway, which is related to apoptosis and antiproliferative effects on tumor cells (87).